6 medicines held by CIS bio International on the Irish market, from the HPRA register of authorised products.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Nanocis 0.24 mg kit for radiopharmaceutical preparation PA0677/006/001 |
Rhenium sulphide | CIS bio International | Not marketed |
| PULMOCIS 2 mg kit for radiopharmaceutical preparation PA0677/003/001 |
Human albumin macro aggregated | CIS bio International | Marketed |
| Quadramet 1.3 GBq/mL solution for injection. EU/1/97/057/001 |
CIS bio International | — | |
| RENOCIS 1 mg kit for radiopharmaceutical preparation PA0677/005/001 |
Succimer | CIS bio International | Marketed |
| STAMICIS 1mg kit for radiopharmaceutical preparation PA0677/018/001 |
Tetrakis (2-methoxy isobutyl isonitrile) copper (i) tetrafluorolborate | CIS bio International | Marketed |
| Striascan 74 MBq /mL solution for injection EU/1/19/1372/001-002 |
IOFLUPANE (1231) | CIS bio International | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 15 August 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.